LISANTI, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 870
EU - Europa 126
AS - Asia 73
AF - Africa 1
Totale 1.070
Nazione #
US - Stati Uniti d'America 868
IT - Italia 52
CN - Cina 32
VN - Vietnam 21
BE - Belgio 15
DE - Germania 13
IE - Irlanda 13
UA - Ucraina 13
IN - India 9
SG - Singapore 8
GB - Regno Unito 7
CZ - Repubblica Ceca 4
RU - Federazione Russa 4
FR - Francia 3
IR - Iran 3
CA - Canada 2
EG - Egitto 1
NO - Norvegia 1
RO - Romania 1
Totale 1.070
Città #
Chandler 127
Fairfield 97
Ashburn 83
Ann Arbor 74
Woodbridge 48
Seattle 46
Houston 44
Wilmington 33
Cambridge 30
New York 26
Beijing 23
Dong Ket 21
Princeton 17
Brussels 15
Dublin 13
Dearborn 12
San Diego 11
Jacksonville 9
Martignacco 9
Redmond 8
Singapore 8
Ogden 7
Washington 7
Augusta 5
Boardman 4
Leawood 4
Udine 4
Brno 3
Jinan 3
Los Angeles 3
Ardabil 2
Des Moines 2
Edinburgh 2
Kunming 2
Norwalk 2
Redwood City 2
Sagrado 2
San Mateo 2
Toronto 2
Trieste 2
Asti 1
Bangalore 1
Cairo 1
Catania 1
Duncan 1
Hyderabad 1
Jinhua 1
Langfang 1
Melfi 1
Mortegliano 1
Mumbai 1
Munich 1
Nanchang 1
Naples 1
Partanna 1
Phoenix 1
Prague 1
Romans 1
Rutigliano 1
San Remo 1
Trento 1
Tuenno 1
Venezia 1
Wenzhou 1
Totale 838
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 118
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach 109
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 82
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 80
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 79
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 74
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 60
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 43
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 38
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 35
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 33
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 31
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 29
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects 3
Totale 1.127
Categoria #
all - tutte 4.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020263 0 14 7 17 14 25 22 33 53 39 27 12
2020/2021292 15 25 43 31 20 8 9 37 6 24 35 39
2021/2022181 16 23 0 4 7 1 12 7 2 22 70 17
2022/2023234 20 35 2 29 32 44 0 25 28 3 11 5
2023/2024152 12 4 9 9 29 54 0 6 10 3 1 15
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.127